491 related articles for article (PubMed ID: 35312727)
21. Serum heme oxygenase 1 (HO-1), soluble FMS like tyrosine kinase (sFlt-1) level, and neonatal outcome in early onset, late onset preeclampsia, and normal pregnancy.
Aldika Akbar MI; Herdiyantini M; Aryananda RA; CIninta N; Wardhana MP; Gumilar KE; Wicaksono B; Ernawati ; Sulistyono A; Aditiawarman ; Joewono HT; Nadir Abdullah ; Dekker G; Dachlan EG; Dikman Angsar M
Hypertens Pregnancy; 2018 Nov; 37(4):175-181. PubMed ID: 30277426
[TBL] [Abstract][Full Text] [Related]
22. Angiogenic profile in the Finnish Genetics of Pre-Eclampsia Consortium (FINNPEC) cohort.
Jääskeläinen T; Heinonen S; Hämäläinen E; Pulkki K; Romppanen J; Laivuori H;
Pregnancy Hypertens; 2018 Oct; 14():252-259. PubMed ID: 29803331
[TBL] [Abstract][Full Text] [Related]
23. Difficulty of predicting early-onset super-imposed preeclampsia in pregnant women with hemodialysis due to diabetic nephropathy by serum levels of sFlt-1, PlGF, and sEng.
Morisawa H; Hirashima C; Sano M; Nagayama S; Takahashi H; Shirasuna K; Ohkuchi A
CEN Case Rep; 2020 May; 9(2):101-105. PubMed ID: 31728843
[TBL] [Abstract][Full Text] [Related]
24. A longitudinal study of circulating angiogenic and antiangiogenic factors and AT1-AA levels in preeclampsia.
Sahay AS; Patil VV; Sundrani DP; Joshi AA; Wagh GN; Gupte SA; Joshi SR
Hypertens Res; 2014 Aug; 37(8):753-8. PubMed ID: 24718301
[TBL] [Abstract][Full Text] [Related]
25. Angiogenic imbalance and plasma lipid alterations in women with preeclampsia from a developing country.
Reyes LM; García RG; Ruiz SL; Broadhurst D; Aroca G; Davidge ST; López-Jaramillo P
Growth Factors; 2012 Jun; 30(3):158-66. PubMed ID: 22486210
[TBL] [Abstract][Full Text] [Related]
26. High early pregnancy body mass index is associated with alterations in first- and second-trimester angiogenic biomarkers.
Beck C; Allshouse A; Silver RM; Grobman WA; Simhan H; Haas D; Reddy UM; Blue NR
Am J Obstet Gynecol MFM; 2022 May; 4(3):100614. PubMed ID: 35283347
[TBL] [Abstract][Full Text] [Related]
27. Effect of antihypertensive therapy with alpha methyldopa on levels of angiogenic factors in pregnancies with hypertensive disorders.
Khalil A; Muttukrishna S; Harrington K; Jauniaux E
PLoS One; 2008 Jul; 3(7):e2766. PubMed ID: 18648513
[TBL] [Abstract][Full Text] [Related]
28. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies.
Holme AM; Roland MC; Henriksen T; Michelsen TM
Am J Obstet Gynecol; 2016 Dec; 215(6):782.e1-782.e9. PubMed ID: 27503620
[TBL] [Abstract][Full Text] [Related]
29. Increased serum strontium levels and altered oxidative stress status in early-onset preeclampsia.
Barneo-Caragol C; Martínez-Morillo E; Rodríguez-González S; Lequerica-Fernández P; Vega-Naredo I; Álvarez FV
Free Radic Biol Med; 2019 Jul; 138():1-9. PubMed ID: 31055131
[TBL] [Abstract][Full Text] [Related]
30. Maternal circulating levels of activin A, inhibin A, sFlt-1 and endoglin at parturition in normal pregnancy and pre-eclampsia.
Reddy A; Suri S; Sargent IL; Redman CW; Muttukrishna S
PLoS One; 2009; 4(2):e4453. PubMed ID: 19412349
[TBL] [Abstract][Full Text] [Related]
31. A longitudinal analysis of angiotensin II type 1 receptor antibody and angiogenic markers in pregnancy.
Aggarwal S; Sunderland N; Thornton C; Xu B; Hennessy A; Makris A
Am J Obstet Gynecol; 2017 Feb; 216(2):170.e1-170.e8. PubMed ID: 27793555
[TBL] [Abstract][Full Text] [Related]
32. Association between Adverse Maternal Clinical Outcomes and Imbalance of Cytokines and Angiogenic Factors in Preterm Preeclampsia.
Nunes PR; Romao-Veiga M; Borges VTM; Matias ML; Ribeiro VR; Costa RAA; Peracoli MTS; Peracoli JC
Rev Bras Ginecol Obstet; 2021 Sep; 43(9):669-675. PubMed ID: 34670301
[TBL] [Abstract][Full Text] [Related]
33. Integration of suboptimal health status evaluation as a criterion for prediction of preeclampsia is strongly recommended for healthcare management in pregnancy: a prospective cohort study in a Ghanaian population.
Anto EO; Roberts P; Coall D; Turpin CA; Adua E; Wang Y; Wang W
EPMA J; 2019 Sep; 10(3):211-226. PubMed ID: 31462939
[TBL] [Abstract][Full Text] [Related]
34. Reduced angiogenic factor expression in intrauterine fetal growth restriction using semiquantitative immunohistochemistry and digital image analysis.
Alahakoon TI; Zhang W; Arbuckle S; Zhang K; Lee V
J Obstet Gynaecol Res; 2018 May; 44(5):861-872. PubMed ID: 29392826
[TBL] [Abstract][Full Text] [Related]
35. Angiogenic profile and smoking in the Finnish Genetics of Pre-Eclampsia Consortium (FINNPEC) cohort.
Jääskeläinen T; Suomalainen-König S; Hämäläinen E; Pulkki K; Romppanen J; Heinonen S; Laivuori H;
Ann Med; 2017 Nov; 49(7):593-602. PubMed ID: 28537456
[TBL] [Abstract][Full Text] [Related]
36. The role of urinary soluble endoglin in the diagnosis of pre-eclampsia: comparison with soluble fms-like tyrosine kinase 1 to placental growth factor ratio.
Buhimschi CS; Baumbusch MA; Dulay AT; Lee S; Wehrum M; Zhao G; Bahtiyar MO; Pettker CM; Ali UA; Funai EF; Buhimschi IA
BJOG; 2010 Feb; 117(3):321-30. PubMed ID: 19943826
[TBL] [Abstract][Full Text] [Related]
37. Correlation between soluble endoglin, vascular endothelial growth factor receptor-1, and adipocytokines in preeclampsia.
Masuyama H; Nakatsukasa H; Takamoto N; Hiramatsu Y
J Clin Endocrinol Metab; 2007 Jul; 92(7):2672-9. PubMed ID: 17426083
[TBL] [Abstract][Full Text] [Related]
38. First trimester serum angiogenic and anti-angiogenic factors in women with chronic hypertension for the prediction of preeclampsia.
Nzelu D; Biris D; Karampitsakos T; Nicolaides KK; Kametas NA
Am J Obstet Gynecol; 2020 Apr; 222(4):374.e1-374.e9. PubMed ID: 31705883
[TBL] [Abstract][Full Text] [Related]
39. Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women.
Rajakumar A; Michael HM; Rajakumar PA; Shibata E; Hubel CA; Karumanchi SA; Thadhani R; Wolf M; Harger G; Markovic N
Placenta; 2005 Aug; 26(7):563-73. PubMed ID: 15993706
[TBL] [Abstract][Full Text] [Related]
40. Soluble fms-like tyrosine kinase-1 and placental growth factor kinetics during and after pregnancy in women with suspected or confirmed pre-eclampsia.
Saleh L; van den Meiracker AH; Geensen R; Kaya A; Roeters van Lennep JE; Duvekot JJ; Verdonk K; Steegers EAP; Russcher H; Danser AHJ; Visser W
Ultrasound Obstet Gynecol; 2018 Jun; 51(6):751-757. PubMed ID: 28600845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
